Strategies for target cell recognition by natural killer cells

Immunological Reviews

Volumn 181, Issue , 2001, Pages 170-184

  Diefenbach, Andreas ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL SURFACE RECEPTOR; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; CELLULAR IMMUNITY; HUMAN; IMMUNE SYSTEM; LIGAND BINDING; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVIEW; SIMULATION; SPECIES DIFFERENCE; T LYMPHOCYTE; TARGET CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; RATS; RECEPTORS, IMMUNOLOGIC;

EID: 0034895155     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1810114.x     Document Type: Review

References (150)

1. The lymphocyte response to primary Moloney sarcoma virus tumors: Definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts
2. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
3. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristic of the killer cell
4. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
5. Biology of natural killer cells
6. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
7. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy
8. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice
9. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
10. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins
11. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48
12. + IL-2 activated natural killer cells
13. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
14. Identification of a human member of the Ly-49 multigene family
15. The human Ly-49L gene
16. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specifities
17. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intra-cellular domains
18. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
19. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
20. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
21. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
22. The Cd94 and Nkg2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
23. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C
24. b
25. b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells
26. Recruitment of tyrosine phosphatase HCP by the NK cell inhibitory receptor
27. Immunoreceptor tyrosine-based inhibition motifs
28. Regulation of the natural killer cell repertoire
29. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
30. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
31. An activating immunoreceptor complex formed by NKG2D and DAP10
32. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
33. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
34. + T cells
35. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs
36. lck via cysteine residues
37. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
38. NK cell receptors
39. The Ly49D receptor activates murine natural killer cells
40. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors
41. d and activates natural killer cell cytotoxicity
42. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
43. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
44. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
45. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
46. Association of DAP12 with activating CD94/NKG2C NK cell receptors
47. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
48. Nonstochastic coexpression of activation receptors on murine natural killer cells
49. p46, a novel natural killer cell-specific surface molecule that mediates cell activation
50. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
51. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
52. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
53. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
54. Genes in a 220-kb region spanning the TNF cluster in human MHC
55. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC
56. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity
57. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
58. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice
59. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
60. Genetic control of natural killing and in vivo tumor elimination by the Chok locus
61. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing
62. Identification of a cell-surface antigen selectively expressed on the natural killer cell
63. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules
64. NKR-P1, a signal transduction molecule on natural killer cells
65. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
66. Mouse NKR-P1. A family of genes selectively coexpressed in adherent lymphokine-activated killer cells
67. Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1
68. cDNA cloning of mouse NKR-P1 and genetic linkage with Ly-49. Identification of a natural killer cell gene complex on mouse chromosome 6
69. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function
70. A 2-MB YAC contig and physical map of the natural killer gene complex on mouse chromosome 6
71. The human natural killer gene complex is located on chromosome 12p12-p13
72. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes
73. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex
74. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium
75. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways
76. + T cells upon NKR-P1 cross-linking
77. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity
78. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
79. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
80. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
81. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells
82. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells
83. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells
84. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å
85. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand
86. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells
87. SH2 domains recognize specific phosphopeptide sequences
88. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells
89. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: Identification of perforin and granzyme B mobilization by functional ERK2
90. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing
91. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity
92. Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
93. A second lineage of mammalian major histocompatibility complex class I genes
94. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
95. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
96. The mouse major histocompatibility complex: Some assembly required
97. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: One of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein
98. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain
99. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: A novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules
100. The molecular and functional characterization of a dominant minor H antigen, H60
101. - T lymphocytes. Antigenic and functional properties
102. Selective cellular natural killing against human leukaemic T cells and thymus
103. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells
104. NK cell-sensitive T-cell subpopulation in thymus: Inverse correlation to host NK activity
105. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells
106. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
107. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
108. A Toll-like receptor recognizes bacterial DNA
109. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
110. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
111. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
112. A human homologue of the Drosophila toll protein signals activation of adaptive immunity
113. The Toll-receptor family and control of innate immunity
114. Innate immunity: The virtues of a nonclonal system of recognition
115. Innate immune recognition: Mechanisms and pathways
116. How to recognize a foreign submarine
117. Natural killer cell receptors: The offs and ons of NK cell recognition
118. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage
119. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies
120. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene
121. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
122. Murine natural killer cells express functional Fc γ receptor II encoded by the Fc gamma R alpha gene
123. Co-association of CD3 ζ with a receptor (CD16) for IgG Fc on human natural killer cells
124. Physical and functional association of p56lck with FcγRIIIA (CD16) in natural killer cells
125. Signal transduction by FcγRIII (CD16) is mediated through the γ chain
126. Tyrosine phosphorylation of the FcγRIII (CD16): ζ complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing
127. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
128. Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: Possible signaling role for the OX-34 determinant during activation by target cells
129. Enhancement of natural killer function through activation of the T11 E rosette receptor
130. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
131. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
132. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
133. A novel receptor involved in T-cell activation
134. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
135. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
136. Activating interactions in human NK cell recognition: The role of 2B4-CD48
137. Human natural killer cell committed thymocytes and their relation to the T cell lineage
138. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line
139. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells
140. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)
141. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii
142. Expression of a variant of CD28 on a subpopulation of human NK cells: Implications for B7-mediated stimulation of NK cells
143. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
144. Triggering of murine NK cells by CD40 and CD86 (B7-2)
145. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes
146. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor
147. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule
148. LAG-3, a novel lymphocyte activation gene closely related to CD4
149. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens
150. Independent modes of natural killing distinguished in mice lacking Lag3